Medication Fact Sheets
|
November 18, 2024

Minoxidil for Women: Benefits, Usage, and Side Effects

Medically Reviewed by
Updated On
November 21, 2024

Hair loss is often considered a men's health concern, but hair loss in women is more common than most people realize, affecting more than 50% of females. It is associated with social stigmas, high healthcare costs, and poor mental health outcomes.  

Minoxidil (Rogaine), the only FDA-approved medication for female pattern hair loss, has gained significant popularity in treating alopecia, highlighting the importance of understanding its benefits, proper usage, and potential side effects for healthcare professionals and patients.

[signup]

Understanding Hair Loss in Women

Alopecia is the medical term that refers to any type of hair loss. The first step in treating hair loss is identifying the cause.

Common Causes of Female Hair Loss

Hair loss in women can be categorized into several types:

1. Androgenetic Alopecia (Female Pattern Hair Loss): The most common type of hair loss in women, characterized by diffuse thinning over the mid-frontal scalp while maintaining the frontal hairline. It is often associated with genetic predisposition and hormonal changes. (4, 13)

2. Telogen Effluvium: Diffuse hair shedding due to a shift of hair follicles into the telogen (resting) phase. It can be triggered by physical or emotional stress, illness, surgery, nutritional deficiencies, or hormonal changes such as postpartum state. (38, 50

3. Alopecia Areata: This is an autoimmune condition resulting in patchy hair loss on the scalp and other body parts. The hair loss is typically sudden and can be reversible.

4. Traction Alopecia: Caused by prolonged tension on the hair from hairstyles such as tight braids or ponytails, leading to hair breakage and loss.

5. Cicatricial (Scarring) Alopecia: This includes conditions like lichen planopilaris and lupus erythematosus, where inflammation leads to permanent destruction of hair follicles and scarring.

6. Trichotillomania: A psychiatric disorder characterized by compulsive hair pulling, leading to noticeable hair loss.

Types of Hair Loss Treatable with Minoxidil

Minoxidil is the first-line treatment for female pattern hair loss. Both topical and oral formulations have shown efficacy in promoting hair regrowth and improving hair density. Studies have also found minoxidil to be effective for treating other types of non-scarring hair loss, including telogen effluvium, alopecia areata, traction alopecia, and chemotherapy-induced alopecia (44, 54). 

How Minoxidil Works for Women

Minoxidil was initially introduced as an oral antihypertensive medication in the 1970s. The hair growth that was observed as a side effect in balding patients led to the development of a topical formulation aimed at treating hair loss. In 1988, the FDA approved topical minoxidil for treating androgenetic alopecia. (46, 48

Mechanism of Action

The way that minoxidil works to promote hair growth isn't completely clear, but it appears to act through two primary mechanisms. 

First, it acts as a vasodilator, widening blood vessels and improving blood flow to hair follicles. A healthy blood supply to hair follicles is necessary for hair follicle growth, maturation, and maintenance. Blood vessels nourish the hair follicle with essential oxygen and nutrients. Loss of this blood supply can lead to hair loss. (33

Second, minoxidil affects two of the four stages of hair growth. The hair growth cycle is defined by four stages: anagen (growth), catagen (transition), telogen (rest), and exogen (shedding). Minoxidil extends the length of the anagen phase. It also shortens the length of the telogen phase, which accelerates the transition from telogen to anagen and promotes hair regrowth. (30

Other ways in which minoxidil promotes hair regrowth include:

  • Minoxidil acts on androgenic receptors and certain enzymes that alter hormonal pathways to reduce dihydrotestosterone and increase estradiol, which prevents hormone-mediated hair loss. 
  • Minoxidil increases vascular endothelial growth factor (VEGF) expression, which improves follicular blood flow. 
  • Minoxidil increases the secretion of certain growth factors that promote hair follicle proliferation.

Differences Between Men's and Women's Minoxidil

The main differences between minoxidil formulations for men and women are the concentration and frequency of application, with women typically using lower concentrations and less frequent applications to balance efficacy and tolerability. (4, 36

Proper Application and Dosage for Women

It is important to apply minoxidil as directed to maximize its benefits and minimize the risk of potential side effects.

Step-by-Step Guide to Using Minoxidil

To apply minoxidil topical solution (31): 

  • Dry your hair and scalp completely.
  • Use the dropper provided to apply 1 mL of the solution directly to the affected area of the scalp. 
  • Wash hands thoroughly after application.
  • Repeat this process twice daily (morning and evening).

To apply minoxidil topical foam (31):

  • Part the hair to expose the affected area of the scalp.
  • Hold the can upside down and press nozzle to put one-half capful on your fingers. 
  • Use your fingers to spread the foam over the areas of hair loss and gently massage into the scalp.
  • Wash your hands immediately after applying the medicine. 
  • Apply the foam once daily.

Dosage Guidelines

The recommended dose and frequency of minoxidil varies between the solution and foam formulations: 

  • 2% Solution: Apply 1 mL twice daily
  • 5% Foam: Apply half a capful once daily

Studies have shown that minoxidil solution and foam are equally effective in stimulating hair growth. The 5% foam offers the advantages of once-daily application and reduced risk of scalp irritation,  primarily because it does not contain propylene glycol. However, minoxidil solution is usually less expensive than the foam. (23

When to Expect Results

Women who use minoxidil consistently can expect to see visible improvement in hair growth approximately eight weeks after starting treatment. Some studies show that some women will begin to see results as soon as six weeks. Patients typically observe maximum results within 3-6 months of consistent use. (3, 17, 29)

It is important to set realistic expectations for patients, emphasizing that individual results can vary. Approximately 60% of women who use minoxidil will not experience hair growth. Continuous and consistent use is also necessary to maintain the benefits, and discontinuation of the medication will lead to the resumption of hair loss. 

Benefits of Minoxidil for Women

Minoxidil has been shown to improve hair growth and density. Studies have demonstrated that both 2% and 5% topical minoxidil formulations effectively increase hair count on the scalp and improve scalp coverage within 6-12 months. (4, 28, 54)

Beyond the physical benefits, treating hair loss with minoxidil can substantially improve self-esteem and mental health. Women using minoxidil experience a notable improvement in self-esteem, a better sense of attractiveness, and overall satisfaction with their appearance (30). This positive impact on emotional well-being cannot go unrecognized, as alopecia can have a profound effect on mental health, leading to anxiety, depression, and low self-esteem.

Side Effects and Risks

While topical minoxidil is generally well tolerated, its use has been associated with the following possible side effects:

  • Minoxidil-Induced Telogen Effluvium (Hair Shedding): The shortened telogen phase of the hair growth cycle can result in excessive hair shedding in some people. Minoxidil shedding is usually temporary, lasting for about 2-8 weeks. 
  • Skin Irritation: scalp redness, discomfort, burning, and scaling
  • Allergic Contact Dermatitis: localized redness and itching at the site of application
  • Hypertrichosis (Excessive Hair Growth): this is a more frequent side effect associated with 5% topical minoxidil solution.

Oral minoxidil is less commonly used to treat hair loss due to its black box warning for pericardial effusion and cardiac tamponade (excessive fluid buildup around the heart that prevents it from working properly). 

Other side effects associated with oral minoxidil include:

  • Low blood pressure
  • Low platelets and white blood cells
  • Breast tenderness and gynecomastia (enlargement of breast tissue)
  • Edema (fluid retention)
  • Tachycardia (increased heart rate)

Addressing Concerns and Managing Side Effects

To prevent the risk of side effects, patients should adhere to proper application procedures, making sure to only apply the solution or foam to the scalp and avoid spreading it to other areas to prevent unwanted hair growth, skin irritation, and excess systemic absorption. 

If patients experience scalp irritation with minoxidil solution, they should consider switching to the foam formulation, which lacks propylene glycol. Propylene glycol is a common cause of contact dermatitis.

Patients should discontinue minoxidil and seek medical advice if they experience severe side effects, including signs of an allergic reaction or cardiovascular symptoms.

Alternatives to Minoxidil for Women

Alternative treatment options are available for women who are unable to tolerate minoxidil or find it ineffective.

Medications

Spironolactone is a potassium-sparing diuretic with anti-androgenic properties, commonly used off-label to treat female pattern hair loss. It works by reducing androgen production and blocking androgen receptors in target tissues, which helps mitigate the effects of androgens on hair follicles. Evidence shows that it can arrest hair loss progression and, in some cases, promote partial hair regrowth. (42

Finasteride helps prevent hair follicle miniaturization and promote hair regrowth by inhibiting the conversion of testosterone to dihydrotestosterone. While some studies have shown that higher doses (2.5 or 5 mg daily) can be effective in postmenopausal women, other studies have found no significant benefit at lower doses (1 mg per day). Due to its teratogenic potential, finasteride should only be prescribed to postmenopausal women. (25, 48, 53

Corticosteroids are a standard treatment for alopecia areata. They work by reducing the autoimmune attack on hair follicles, thereby promoting hair regrowth. Corticosteroids can be administered in several ways: topically, intralesionally, and orally. Intralesional injections are typically the preferred method due to their high efficacy and lower risk of systemic side effects. (52

Procedures

Low-level light therapy (LLLT) is a non-invasive treatment that utilizes specific wavelengths of light to stimulate hair growth. The absorption of light by hair follicles induces molecular changes that promote cellular proliferation and reduce inflammation to support hair growth. (1, 19

Hair transplant surgery is a medical procedure used to treat hair loss by relocating hair follicles from a donor area, typically the back or sides of the scalp, to areas experiencing thinning or baldness. Once transplanted, these follicles continue to grow naturally in their new location.

Natural and Lifestyle-Based Approaches

There are many types of supplements that may help support hair health. These formulas often contain the following ingredients:

  • Biotin: enhances keratin production
  • Iron: delivers oxygen to hair follicles and acts as a cofactor for enzymes involved in DNA and keratin synthesis
  • Zinc: reduces intrafollicular inflammation and supports protein synthesis
  • Ashwagandha: balances stress hormones
  • Saw Palmetto: lowers dihydrotestosterone levels 

Lifestyle changes can also help to support hair health and potentially promote new hair growth:

  • Eat a balanced, anti-inflammatory diet to reduce systemic inflammation levels and ensure adequate intake of macro- and micronutrients required for healthy hair.
  • Avoid stressors and reduce stress by getting enough sleep, establishing a healthy work-life balance, practicing mind-body therapies, and supplementing with adaptogenic herbs.
  • Quit smoking and avoid second-hand smoke. Smoking contributes to hair loss by reducing blood flow to hair follicles, damaging DNA, and inducing inflammation. (2, 35

Who Should Use Minoxidil?

Ideal candidates for minoxidil for treating hair loss are women with androgenetic alopecia (female pattern hair loss). Minoxidil is also used off-label for treating telogen effluvium and alopecia areata.

Contraindications and Situations to Avoid

Patients who are not good candidates for minoxidil include (27): 

  • Women with hair loss of unknown cause
  • Women under the age of 18
  • Women with red, inflamed, irritated, or infected scalp conditions
  • Women who are pregnant or breastfeeding

[signup]

Key Takeaways

  • If you are struggling with hair loss, talk to your doctor about minoxidil as one treatment option. Minoxidil is a well-established, FDA-approved treatment for female pattern hair loss. It is also commonly used off-label for treating other types of hair loss in women, including telogen effluvium and alopecia areata.
  • Consistent use of minoxidil is required to achieve its full benefits. In as little as six weeks, women can begin seeing hair growth and regain confidence. 
  • By working closely with their healthcare providers to address the underlying causes of hair loss, women can adopt an integrative approach that optimizes short- and long-term results in their journey toward healthier, fuller hair.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. Amer, M., Nassar, A., Attallah, H., et al. (2021). Results of low‐level laser therapy in the treatment of hair growth: An Egyptian experience. Dermatologic Therapy, 34(3). https://doi.org/10.1111/dth.14940
  2. Babadjouni, A., Pouldar Foulad, D., Hedayati, B., et al. (2021). The Effects of Smoking on Hair Health: A Systematic Review. Skin Appendage Disorders, 7(4), 251–264. https://doi.org/10.1159/000512865
  3. Badri, T., Nessel, T. A., & Kumar D, D. (2020). Minoxidil. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482378/
  4. Blume-Peytavi, U., Hillmann, K., Dietz, E., et al. (2011). A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. Journal of the American Academy of Dermatology, 65(6), 1126-1134.e2. https://doi.org/10.1016/j.jaad.2010.09.724
  5. Camacho-Martínez, F. M. (2009). Hair Loss in Women. Seminars in Cutaneous Medicine and Surgery, 28(1), 19–32. https://doi.org/10.1016/j.sder.2009.01.001
  6. Choi, N., Shin, S., Song, S., et al. (2018). Minoxidil Promotes Hair Growth through Stimulation of Growth Factor Release from Adipose-Derived Stem Cells. International Journal of Molecular Sciences, 19(3), 691. https://doi.org/10.3390/ijms19030691
  7. Cloyd, J. (2023, March 15). The relationship between the sleep stress cycle. Rupa Health. https://www.rupahealth.com/post/the-relationship-between-the-sleep-stress-cycle
  8. Cloyd, J. (2023, September 8). A Functional Medicine Approach to Addressing Hair Loss in Women. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-addressing-hair-loss-in-women
  9. Cloyd, J. (2024, January 12). Saw palmetto's role in hormonal balance and prostate health. Rupa Health. https://www.rupahealth.com/post/saw-palmettos-role-in-hormonal-balance-and-prostate-health
  10. Cloyd, J. (2024, February 16). Nutrient deficiencies responsible for hair loss. Rupa Health. https://www.rupahealth.com/post/nutrient-deficiencies-responsible-for-hair-loss
  11. Cloyd, J. (2024, September 17). Enhancing Psychological Wellbeing Through Exercise: The Role of Self-Esteem. Rupa Health. https://www.rupahealth.com/post/enhancing-psychological-wellbeing-through-exercise-the-role-of-self-esteem
  12. Cox, A. D. (2022, December 2). Adaptogen Herbs: Evidence, Medicinal Benefits, & More. Rupa Health. https://www.rupahealth.com/post/adaptogens
  13. DePorto, T. (2023, January 11). Zinc 101. Rupa Health. https://www.rupahealth.com/post/zinc
  14. Devjani, S., Ezemma, O., Kelley, K. J., et al. (2023). Androgenetic Alopecia: Therapy Update. Drugs, 83(8), 701–771. https://doi.org/10.1007/s40265-023-01880-x
  15. Dhami, L. (2021). Psychology of Hair Loss Patients and Importance of Counseling. Indian Journal of Plastic Surgery: Official Publication of the Association of Plastic Surgeons of India, 54(4), 411–415. https://doi.org/10.1055/s-0041-1741037
  16. Feaster, B., Onamusi, T., Cooley, J. E., et al. (2022). Oral minoxidil use in androgenetic alopecia and telogen effluvium. Archives of Dermatological Research, 315(2), 201–205. https://doi.org/10.1007/s00403-022-02331-5
  17. Goren, A., Shapiro, J., Roberts, J., et al. (2014). Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatologic Therapy, 28(1), 13–16. https://doi.org/10.1111/dth.12164
  18. Guo, E. L., & Katta, R. (2017). Diet and hair loss: effects of nutrient deficiency and supplement use. Dermatology Practical & Conceptual, 7(1), 1–10. https://doi.org/10.5826/dpc.0701a01
  19. Guo, Y., Qu, Q., Chen, J., et al. (2021). Proposed mechanisms of low-level light therapy in the treatment of androgenetic alopecia. Lasers Med Sci, 36(4), 703–713. https://doi.org/10.1007/s10103-020-03159-z
  20. Gupta, A. K., & Foley, K. A. (2014). 5% Minoxidil: treatment for female pattern hair loss. Skin Therapy Letter, 19(6), 5–7. https://pubmed.ncbi.nlm.nih.gov/25807073/
  21. Gupta, A. K., Talukder, M., Venkataraman, M., et al. (2021). Minoxidil: a comprehensive review. Journal of Dermatological Treatment, 33(4), 1–11. https://doi.org/10.1080/09546634.2021.1945527
  22. Hair Loss in Women. (2018). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/16921-hair-loss-in-women
  23. Hair Transplant. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/21519-hair-transplant
  24. Hannemann, K. (2024, November 4). Minoxidil Foam vs. Liquid for Hair Loss: 4 Differences to Consider. GoodRx. https://www.goodrx.com/minoxidil-non-prescription/foam-vs-liquid#cost
  25. Iamsumang, W., Leerunyakul, K., & Suchonwanit, P. (2020). Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date. Drug Design, Development and Therapy, 14, 951–959. https://doi.org/10.2147/DDDT.S240615
  26. Kacar, S. D., Soyucok, E., Ozuguz, P., et al. (2016). The perceived stigma in patients with alopecia and mental disorder: A comparative study. International Journal of Trichology, 8(3), 135–140. https://doi.org/10.4103/0974-7753.189005
  27. Label: REGOXIDINE (FOR WOMEN)- minoxidil aerosol, foam. (2022). DailyMed; National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60cc177-700c-4007-be1a-2cb74824e657
  28. Lucky, A. W., Piacquadio, D. J., Ditre, C. M., et al. (2004). A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Journal of the American Academy of Dermatology, 50(4), 541–553. https://doi.org/10.1016/j.jaad.2003.06.014
  29. Maholy, N. (2023, April 14). How to reduce stress through mind-body therapies. Rupa Health. https://www.rupahealth.com/post/how-to-reduce-stress-through-mind-body-therapies
  30. McMichael, A., Pham, H., von Grote, E., et al. (2016). Efficacy and Safety of Minoxidil 2% Solution in Combination With a Botanical Hair Solution in Women With Female Pattern Hair Loss/Androgenic Alopecia. Journal of Drugs in Dermatology: JDD, 15(4), 398–404. https://pubmed.ncbi.nlm.nih.gov/27050694/
  31. Messenger, A. G., & Rundegren, J. (2004). Minoxidil: mechanisms of action on hair growth. British Journal of Dermatology, 150(2), 186–194. https://doi.org/10.1111/j.1365-2133.2004.05785.x
  32. Minoxidil (Topical Route). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/minoxidil-topical-route/description/drg-20068750
  33. Mostaghimi, A., Xenakis, J., Meche, A., et al. (2022). Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA. Dermatology and Therapy, 12(4), 1027–1040. https://doi.org/10.1007/s13555-022-00710-4
  34. Murphrey, M. B., Agarwal, S., & Zito, P. M. (2021). Anatomy, Hair. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513312/
  35. Mysore, V., & Kavadya, Y. (2022). Role of smoking in androgenetic alopecia: A systematic review. International Journal of Trichology, 14(2), 41. https://doi.org/10.4103/ijt.ijt_59_21
  36. Natarelli, N., Gahoonia, N., & Sivamani, R. K. (2023). Integrative and Mechanistic Approach to the Hair Growth Cycle and Hair Loss. Journal of Clinical Medicine, 12(3), 893. https://doi.org/10.3390/jcm12030893
  37. Nioxin Hair Regrowth Treatment for Men. (2023). DailyMed; National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e07b621d-4266-d3c0-e053-2a95a90ae6de
  38. Olsen, E. A., & Weiner, M. S. (1987). Topical minoxidil in male pattern baldness: Effects of discontinuation of treatment. Journal of the American Academy of Dermatology, 17(1), 97–101. https://doi.org/10.1016/s0190-9622(87)70179-0
  39. Phillips, T. G., Slomiany, W. P., & Allison, R. (2017). Hair Loss: Common Causes and Treatment. American Family Physician, 96(6), 371–378. https://pubmed.ncbi.nlm.nih.gov/28925637/
  40. Pulickal, J. K., & Kaliyadan, F. (2021). Traction Alopecia. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470434/
  41. Randolph, M., & Tosti, A. (2020). Oral minoxidil treatment for hair loss: A review of efficacy and safety. Journal of the American Academy of Dermatology, 84(3). https://doi.org/10.1016/j.jaad.2020.06.1009
  42. Rathnayake, D., & Sinclair, R. (2010). Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Dermatologic Clinics, 28(3), 611–618. https://doi.org/10.1016/j.det.2010.03.011
  43. Scarring (Cicatricial) Alopecia. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/24582-scarring-alopecia
  44. Schurr, L., & Cheng, H. (2022). Contact Allergy to Propylene Glycol. DermNet. https://dermnetnz.org/topics/contact-allergy-to-propylene-glycol
  45. Sharma, A. N., Michelle, L., Juhasz, M., et al. (2020). Low‐dose oral minoxidil as treatment for non‐scarring alopecia: a systematic review. International Journal of Dermatology, 59(8), 1013–1019. https://doi.org/10.1111/ijd.14933
  46. Shen, Y., Zhu, Y., Zhang, L., et al. (2023). New Target for Minoxidil in the Treatment of Androgenetic Alopecia. Drug Design Development and Therapy, Volume 17, 2537–2547. https://doi.org/10.2147/dddt.s427612
  47. Stoehr, J. R., Choi, J. N., Colavincenzo, M., et al. (2019). Off-Label Use of Topical Minoxidil in Alopecia: A Review. American Journal of Clinical Dermatology, 20(2), 237–250. https://doi.org/10.1007/s40257-018-0409-y
  48. Stout, S. C., & Stumpf, J. L. (2010). Finasteride Treatment of Hair Loss in Women. Ann Pharmacother, 44(6), 1090–1097. https://doi.org/10.1345/aph.1m591
  49. Suchonwanit, P., Thammarucha, S., & Leerunyakul, K. (2019). Minoxidil and its use in hair disorders: a review. Drug Design, Development and Therapy, Volume 13, 2777–2786. https://doi.org/10.2147/dddt.s214907
  50. Sweetnich, J. (2023, May 10). Complementary and Integrative Medicine Approaches to Contact Dermatitis: Allergy Testing and Treatment. Rupa Health. https://www.rupahealth.com/post/integrative-dermatological-approaches-to-contact-dermatitis
  51. Telogen Effluvium. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/24486-telogen-effluvium
  52. Thiedke, C. C. (2022). Alopecia in women. American Family Physician, 67(5), 1007–1014. https://pubmed.ncbi.nlm.nih.gov/12643360/
  53. Trüeb, R. M. (2004). Finasteride Treatment of Patterned Hair Loss in Normoandrogenic Postmenopausal Women. Dermatology, 209(3), 202–207. https://doi.org/10.1159/000079890
  54. Vastarella, M., Cantelli, M., Patrì, A., et al. (2020). Efficacy and safety of oral minoxidil in female androgenetic alopecia. Dermatologic Therapy, 33(6). https://doi.org/10.1111/dth.14234
  55. Villani, A., Fabbrocini, G., Ocampo‐Candiani, J., et al. (2021). Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose. Journal of the European Academy of Dermatology and Venereology, 35(7), 1485–1492. https://doi.org/10.1111/jdv.17216
  56. Vitamin B7. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/vitamin-b7
  57. Weinberg, J. L. (2023, August 2). Integrative and Complementary Approach to Alopecia Areata: Testing, Nutrition, Supplements, and More. Rupa Health. https://www.rupahealth.com/post/integrative-and-complementary-approach-to-alopecia-areata
  58. Yoshimura, H. (2023, September 20). Top Labs To Run On Your Patients Who Suffer From Obsessive-Compulsive Disorder (OCD). Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-patients-who-suffer-from-obsessive-compulsive-disorder-ocd
  59. Yum, S., Jeong, S., Kim, D., et al. (2017). Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase. Int J Mol Sci, 19(1), 53–53. https://doi.org/10.3390/ijms19010053
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a Free Live Class that dives into how popular diets impact the gut microbiome, the clinical dietary needs of your gut, biomarkers to test to analyze gut health, and gain a clear understanding of the Doctor’s Data GI360™ profile. Register here.